426 related articles for article (PubMed ID: 2567647)
1. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
De Natale G; De Natale F; Marino A
Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic options for the control of peptic ulcer disease.
Levine JB
Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
[No Abstract] [Full Text] [Related]
3. Drug therapy of peptic ulcer disease.
Ching CK; Lam SK
Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
[TBL] [Abstract][Full Text] [Related]
4. Medical treatment of peptic ulcers.
Deveney CW; Deveney KE
Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
[TBL] [Abstract][Full Text] [Related]
5. [Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].
Evseev MA; Ivakhov GB; Golovin RA
Khirurgiia (Mosk); 2009; (3):46-52. PubMed ID: 19391208
[No Abstract] [Full Text] [Related]
6. Current concepts in clinical therapeutics: peptic ulcer disease.
Siepler JK; Mahakian K; Trudeau WT
Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
[TBL] [Abstract][Full Text] [Related]
7. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
Miagkova LP; Grebenev AL; Kkhorshed AM
Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773
[No Abstract] [Full Text] [Related]
8. Famotidine: clinical applications of a new H2-receptor antagonist. May 16, 1986, Carmel, California.
Am J Med; 1986 Oct; 81(4B):1-64. PubMed ID: 2877568
[No Abstract] [Full Text] [Related]
9. [Mechanism of action and therapeutic effectiveness of histamine H2 receptor blockaders in peptic ulcer].
Glubochenko VG; Shcherbak VV
Vrach Delo; 1985 Feb; (2):13-5. PubMed ID: 2859701
[No Abstract] [Full Text] [Related]
10. [A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer].
Ivashkin VT; Tkachenko EI; Grinevich VB; Sultanov VK; Inozemtsev SA
Ter Arkh; 1989; 61(8):59-62. PubMed ID: 2573963
[TBL] [Abstract][Full Text] [Related]
11. [Antacids and muscarinic and histamine H2 receptor blockaders in the treatment of peptic ulcer].
Ivashkin VT; Minasian GA
Klin Med (Mosk); 1987 Jan; 65(1):24-31. PubMed ID: 2882061
[No Abstract] [Full Text] [Related]
12. Peptic ulceration.
Weir DG
Br Med J (Clin Res Ed); 1988 Jan; 296(6616):195-200. PubMed ID: 2892567
[No Abstract] [Full Text] [Related]
13. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
14. [H2 receptor antagonists and intragastric acidity].
Dammann HG; Walter TA; Müller P; Simon B
Dtsch Med Wochenschr; 1984 Nov; 109(46):1767-9. PubMed ID: 6094136
[No Abstract] [Full Text] [Related]
15. Medical treatment of peptic ulcer disease.
Andersen BN
Acta Chir Scand Suppl; 1988; 547():88-92. PubMed ID: 2906493
[TBL] [Abstract][Full Text] [Related]
16. [Current locally acting agents in the treatment of peptic ulcer].
Ryss ES
Klin Med (Mosk); 1986 Aug; 64(8):18-27. PubMed ID: 2878103
[No Abstract] [Full Text] [Related]
17. [Pathophysiologic bases of the pharmacotherapy of peptic ulcer].
Grigor'ev PIa; Isakov VA; Vasil'eva ZI
Klin Med (Mosk); 1988 Nov; 66(11):19-27. PubMed ID: 2907071
[No Abstract] [Full Text] [Related]
18. Drugs for treatment of peptic ulcers.
Med Lett Drugs Ther; 1991 Nov; 33(858):111-4. PubMed ID: 1682791
[No Abstract] [Full Text] [Related]
19. [Which drug for peptic ulcer?].
Hameeteman W; Tytgat GN
Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643
[No Abstract] [Full Text] [Related]
20. [Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer].
Belousov IuB; Karpov OI; Belousov DIu; Beketov AS
Ter Arkh; 2007; 79(2):58-66. PubMed ID: 17460971
[No Abstract] [Full Text] [Related]
[Next] [New Search]
